12:00 AM
Apr 29, 2013
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Vivus sales and marketing update

Vivus reported that the number of prescriptions shipped for obesity drug Qsymia phentermine/topiramate was 16,733 in January, 18,417 in February and 23,812 in March. In April, FDA...

Read the full 124 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >